Climb Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLYM research report →
About the company
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody.
- CEO
- Aoife Brennan BCh MMSc
- IPO
- 2021
- Employees
- 17
- HQ
- Wellesley Hills, DE, US
Price Chart
- Market Cap
- $879.58M
- P/E
- -16.54
- P/S
- 0.00
- P/B
- 5.94
- EV/EBITDA
- -16.55
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -31.46%
- ROIC
- -40.44%
- Revenue
- $0 · 0.00%
- Net Income
- $-59,851,000 · 19.01%
- EPS
- $-0.88 · 42.48%
- Op Income
- $-67,883,000
- FCF YoY
- -250.48%
- 52W High
- $13.69
- 52W Low
- $1.21
- 50D MA
- $11.07
- 200D MA
- $5.98
- Beta
- 0.10
- Avg Volume
- 1.11M
Get TickerSpark's AI analysis on CLYM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 70,284 |
| Jun 29, 26 | Celebi Breanna Maurine | other | 70,284 |
| Jun 29, 26 | Celebi Breanna Maurine | other | 0 |
| Jun 27, 26 | Brennan Aoife | other | 68,750 |
| Jun 27, 26 | Brennan Aoife | other | 68,750 |
| Jun 29, 26 | Brennan Aoife | sell | 30,902 |
| Jun 5, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 40,000 |
| Jun 5, 26 | Levin Andrew David | other | 40,000 |
| Jun 5, 26 | Drapkin Kimberlee C | other | 40,000 |
| Jun 5, 26 | WILLIAMS DOUGLAS E | other | 40,000 |
Our CLYM coverage
Recent articles, reports, and earnings notes.
No research on CLYM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLYM report →Similar companies
Peers in the same neighborhood.